FEB 08, 2017 12:25 PM PST

Two B Cells Types, Two Completely Different Life Roles

WRITTEN BY: Kara Marker

A specialized form of immune B cells exist in the human spleen to protect the body from specific types of bacteria. But there is a unique molecular process that needs to happen in order for immature B cells to become these specialized cells over other types of cells.

From The Flanders Institute for Biotechnology (VIB), researchers investigated the pathways behind the differentiation of specialized B cells called MZB cells, named for the marginal zone in the spleen where they congregate. The spleen plays the important role of filtering the blood for bacteria and other foreign particles. 

A  section taken from a spleen reveals splenic tissue with sheets of immune cells. Source: Cytopath Veterinary Pathology Laboratory

MZB cells are involved in antibody “training” to prepare them for the fight against infectious disease, mainly producing antibodies that target encapsulated bacterial like pneumococcus. However, MZB cells are not the only immune cells doing work in the spleen. They share some space with another B cell subtype called follicular B cells, so what makes precursor cells “decide” to become MZB cells versus follicular B cells?

"We had a 'eureka!' moment after discovering that a little-known protein, Taok3, brings a certain proteinase, ADAM10, to the surface of the immature B cell that triggers its development into an MZB cell,” explained VIB’s Hamida Hammad. “Without that special event, immature B cells can only develop into follicular B cells." Hammad and the team from VIB started their study with the knowledge that Taok3 protein triggers, somehow, the development of MZB cells.

Identifying the role of Taok3 protein in the development of MZB cells provides new possibilities for treatments of genetic conditions, asthma, and diabetes, which might rely on the immune response which includes MZB cells.

VIB researchers confirmed the role of Taok3 in mice studies by removing the Taok3 gene. Without it, the mice would make almost any B cell type except MZB cells. They were also especially susceptible to respiratory infection from pneumococcus bacteria.

"With an abundance of only follicular B cells, Taok3-free mice are less capable of fighting these types of bacteria effectively,” Hammad said.

“This research has generated insights that are very relevant to new therapies to a range of important diseases,” said VIB’s Bart Lambrecht. “It goes to show that basic science sometimes leads to unexpected - and important - applications."

The VIB’s new study was published in the journal Nature Immunology.

Source: The Flanders Institute for Biotechnology (VIB)

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 18, 2018
Immunology
AUG 18, 2018
Two Proteins Play Unexpected Role in Immune System Regulators
Two proteins, PLD3 and PLD4, discovered to have role in immune system detection and response to pathogens....
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Re-sensitizing Drug-resistant Human Tumor Cells
Understanding how cancer cells avoid death despite their DNA being damaged will create new strategies to enhance cancer cell killing through chemotherapy t...
OCT 31, 2018
Immunology
OCT 31, 2018
Masking the Pathogen
Researchers at Penn State have revealed bacterial pathogens capable of creating components used for DNA replication without the use of metal ions allowing them to evade the immune system...
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
NOV 20, 2018
Immunology
NOV 20, 2018
Survival of the SCID Patient
A team of scientists reviewed over 600 SCID patients medical records to establish the relationship between genetics and survival rates....
Loading Comments...